Ontology highlight
ABSTRACT:
SUBMITTER: Kato K
PROVIDER: S-EPMC6619336 | biostudies-literature | 2019 Jul
REPOSITORIES: biostudies-literature
Kato Kota K den Adel Martin M Groenendaal-van de Meent Dorien D Ohtsu Yoshiaki Y Takada Akitsugu A Katashima Masataka M
Clinical pharmacology in drug development 20181109 5
Amenamevir is an inhibitor of the helicase-primase enzyme complex developed for the treatment of varicella zoster virus. This mass balance study investigated the absorption, metabolism, and excretion of a single dose (200 mg) of <sup>14</sup> C-labeled amenamevir in healthy male volunteers. Blood, urine, and feces samples were collected for up to 8 days after the dose. Safety and tolerability were assessed through voluntary reporting of adverse events, physical examination, and clinical laborato ...[more]